(XHE) SPDR S&P Health Care - Ratings and Ratios

Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US78464A5810

Medical Devices, Equipment, Supplies, Diagnostics, Tools

Description: XHE SPDR S&P Health Care

The SPDR S&P Health Care Equipment ETF (XHE) is designed to mirror the performance of the S&P Health Care Equipment Select Industry Index. To achieve this, the fund adopts a sampling strategy, investing at least 80% of its total assets in the securities that comprise the index, effectively replicating the health care equipment segment of the broader S&P Total Market Index (S&P TMI).

The health care equipment sector is a critical component of the healthcare industry, encompassing companies involved in the production of medical equipment and devices. This includes a wide range of products from surgical instruments and diagnostic equipment to medical implants and monitoring devices. The funds focus on this specific segment allows investors to target their investments towards the healthcare equipment industry, potentially capitalizing on trends and growth opportunities within this niche.

From a technical analysis perspective, examining the moving averages indicates a potential trend reversal. With the SMA20 (78.75) and SMA50 (80.41) being lower than the current price (82.75), it suggests a short-term uptrend. However, the SMA200 (87.35) is significantly higher, indicating a longer-term downtrend. The Average True Range (ATR) of 2.36, or 2.86%, signifies moderate volatility, suggesting that while there are fluctuations, they are not extreme. Considering the 52-week high (95.73) and low (72.34), the current price is roughly mid-range, suggesting potential for both upward and downward movement.

Fundamentally, the Assets Under Management (AUM) of $177.22M USD indicate a relatively smaller ETF, which can sometimes result in lower liquidity and potentially higher volatility. However, it also signifies a focused investment vehicle that is specifically targeting the healthcare equipment sector, potentially appealing to investors looking for niche exposure.

Forecasting the future performance of XHE involves considering both the technical and fundamental data. Given the current technical indicators and the fundamental focus of the ETF, a potential forecast could involve a cautious optimism in the short term due to the uptrend indicated by the SMA20 and SMA50. However, the longer-term downtrend suggested by the SMA200 and the moderate volatility indicated by the ATR should temper expectations. Investors should monitor the AUM for signs of significant inflows or outflows, which could impact liquidity and volatility. A break above the SMA200 could signal a longer-term uptrend, while a drop below the 52-week low could indicate further declines. Thus, a balanced view, taking into account both technical trends and fundamental data, is essential for making informed investment decisions regarding XHE.

Additional Sources for XHE ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

XHE ETF Overview

Market Cap in USD 164m
Category Health
TER 0.35%
IPO / Inception 2011-01-26

XHE ETF Ratings

Growth Rating -38.2
Fundamental -
Dividend Rating 36.5
Rel. Strength -17.7
Analysts -
Fair Price Momentum 74.95 USD
Fair Price DCF -

XHE Dividends

Dividend Yield 12m 0.04%
Yield on Cost 5y 0.03%
Annual Growth 5y 100.00%
Payout Consistency 45.4%
Payout Ratio %

XHE Growth Ratios

Growth Correlation 3m 48.3%
Growth Correlation 12m -49.4%
Growth Correlation 5y -75%
CAGR 5y -2.19%
CAGR/Max DD 5y -0.04
Sharpe Ratio 12m 0.53
Alpha -18.43
Beta 0.714
Volatility 22.12%
Current Volume 14.9k
Average Volume 20d 9.1k
Stop Loss 77.2 (-3.4%)
What is the price of XHE shares?
As of July 14, 2025, the stock is trading at USD 79.95 with a total of 14,860 shares traded.
Over the past week, the price has changed by +0.02%, over one month by -0.14%, over three months by +4.40% and over the past year by -7.44%.
Is SPDR S&P Health Care a good stock to buy?
Probably not. Based on ValueRay´s Analyses, SPDR S&P Health Care (NYSE ARCA:XHE) is currently (July 2025) not a good stock to buy. It has a ValueRay Growth Rating of -38.21 and therefor a somwhat technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XHE is around 74.95 USD . This means that XHE is currently overvalued and has a potential downside of -6.25%.
Is XHE a buy, sell or hold?
SPDR S&P Health Care has no consensus analysts rating.
What are the forecasts for XHE share price target?
According to our own proprietary Forecast Model, XHE SPDR S&P Health Care will be worth about 85.9 in July 2026. The stock is currently trading at 79.95. This means that the stock has a potential upside of +7.4%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 85.9 7.4%